|
A-Al AL-AZ B C-CD25 CD26-CD301 CDC-CY D E F G H I -IgG IgM-IT J K L M N O P-PL PM-PY Q R S T U V W X Y Z |
|
|
|
B = Biodesign; I = ICL; IB = Innov. Res. Biol.; IR = Innov. Res.; M = Moss; N = LabVision |
| Kat.-Nr. | Beschreibung | Klon | Produkt | Firma |
| B01238G | Bacillus anthracis Ames strain (Purified), Host Goat | Ab | B | |
| B01239G | Bacillus anthracis Ames,Sterne + Vollum strain (Purified), Host Goat | Ab | B | |
| B01240G | Bacillus anthracis Sterne strain (Purified), Host Goat | Ab | B | |
| B01241G | Bacillus anthracis Vollum strain (Purified), Host Goat | Ab | B | |
| B88940R | Bacillus anthracis Edema Factor (EF) C-terminal | Ab | B | |
| C86701M | Bacillus anthracis Lethal Factor (Anthrax) | BAL0105 | Ab | B |
| C86710M | Bacillus anthracis Lethal Factor (Anthrax) | BAL0106 | Ab | B |
| C86542M | Bacillus anthracis Lethal Factor (Anthrax) | B743M | Ab | B |
| C86543M | Bacillus anthracis Lethal Factor (Anthrax) | B414M | Ab | B |
| B88710R | Bacillus anthracis Lethal Factor (Anthrax) C-terminal | Ab | B | |
| B88510R | Bacillus anthracis Lethal Factor (Anthrax) Middle | Ab | B | |
| C86110M | Bacillus anthracis Protective Antigen (Anthrax) | BAP0101 | Ab | B |
| C86201M | Bacillus anthracis Protective Antigen (Anthrax) | BAP0102 | Ab | B |
| C86301M | Bacillus anthracis Protective Antigen (Anthrax) | BAP0103 | Ab | B |
| C86410M | Bacillus anthracis Protective Antigen (Anthrax) | BAP0104 | Ab | B |
| C86501M | Bacillus anthracis Protective Antigen (Anthrax) | BAP0105 | Ab | B |
| C86601M | Bacillus anthracis Protective Antigen (Anthrax) (Purified) | BAP0106 | Ab | B |
| C86601P | Bacillus anthracis Protective Antigen (Anthrax) (HRP) | BAP0106 | Ab | B |
| C86613M | Bacillus anthracis Protective Antigen (Anthrax) | C3 | Ab | B |
| B88330R | Bacillus anthracis Protective Antigen (PA) C-terminal | Ab | B | |
| B88410R | Bacillus anthracis Protective Antigen (PA) Middle | Ab | B | |
| C86702M | Bacillus anthracis Spore Antigen (Anthrax) | SA27 | Ab | B |
| C86702B | Bacillus anthracis Spore Antigen (Anthrax) (Biotin) | SA27 | Ab | B |
| C86910M | Bacillus anthracis Spore Antigen (Anthrax) | SA26 | Ab | B |
| B65413R | Bacillus spores | Ab | B | |
| C01260M | Bacteroides distasonis | B135M | Ab | B |
| C01259M | Bacteroides theataiotaomicron | B134M | Ab | B |
| K67650M | BAD | 5E6 | Ab | B |
| IR300001 | BAFFtrn (TALL-1, BLyS, THANK)-muCD8 Fusion Protein, Human | Protein | IR | |
| IMS-BCN | Balb-C Mouse Plasma | IR | ||
| IMS-BCSER | Balb-C Mouse Serum | IR | ||
| N01260M | BALB/c Mouse Serum | B | ||
| RB-1520 | Bak Ab-2 | Ab | N | |
| IR7477050 | Barbiturate (Purified), Host Rabbit | Ab | IR | |
| IR7479050 | Barbiturate (Antiserum), Host Sheep | Ab | IR | |
| G49648M | Barbiturates (BAR) | B648M | Ab | B |
| G49649M | Barbiturates (BAR) | B649M | Ab | B |
| P91041M | Bax | 4F11 | Ab | B |
| MS-711 | Bax Ab-1 | 2D2 | Ab | N |
| MS-714 | Bax Ab-4 | 6A7 | Ab | N |
| K88910R | B-cell Receptor Associated Protein 29 (BAP29), Middle Region | Ab | B | |
| K88911R | B-cell Receptor Associated Protein 31 (BAP31), C-terminal | Ab | B | |
| BCIP | BCIP, Substrate for ALP suitable for Blotting and IHC | M | ||
| NBTM | BCIP/NBT, Blotting Substrate for ALP (1 component) | M | ||
| NBTH | BCIP/NBT Plus, Substrate for ALP suitable for Blotting, IHC and in situ hybridization | M | ||
| TNBT | BCIP/TNBT, similar BCIP/NBT Plus but more sensitive (1 component) | M | ||
| MS-123 | bcl-2a Ab-1 | 100/D5 | Ab | N |
| MS-597 | bcl-2a Ab-3 | 8C8 | Ab | N |
| K01314R | Bcl-2 Associated Death promoter (BAD), Human (Host Rabbit) | Ab | B | |
| K01315R | Bcl-2 Associated Death promoter (BAD), phosph. at serine 112 | Ab | B | |
| K88101R | Bcl-2 Inhibitor of Transcription 1 (Bit1), Middle Region | Ab | B | |
| K55300H | Bcl-3 (B-cell CLL/lymphoma 3) | B325H | Ab | B |
| MS-579 | bcl-6 Ab-1 | P1F6 | Ab | N |
| MS-1114 | bcl-6 Ab-2 | BL6.02 (PG-B6p) | Ab | N |
| MS-1897 | bcl-6 Ab-3 | P1F6 + BL6.02 | Ab | N |
| MS-715 | bcl-X Ab-1 | 2H12 | Ab | N |
| MS-1334 | bcl-XL Ab-2 | 7D9 | Ab | N |
| IBG-N | Beagle Plasma | IR | ||
| IBG-SER | Beagle Serum | IR | ||
| K88100R | Beclin 1, C-terminal | Ab | B | |
| S4D03-342 | Benzodiazepine | Ab | B | |
| G49650M | Benzodiazepine (BZO) | B650M | Ab | B |
| G49651M | Benzodiazepine (BZO) | B651M | Ab | B |
| Y48603B | Benzodiazepine (BZO) BSA Conjugate | B | ||
| IR7479060 | Benzodiazepine (Antiserum), Host Sheep | Ab | IR | |
| IR74750470 | Benzoylecgonine (Antiserum), Host Goat | Ab | IR | |
| G45132M | Benzoylecgonine | IP3G2 | Ab | B |
| G45206M | Benzoylecgonine | F1#4H113B9D1 | Ab | B |
| G45207M | Benzoylecgonine | 421A | Ab | B |
| G82911M | Benzoylecgonine | P93 | Ab | B |
| G49846M | Benzoylecgonine (BZE) | B846M | Ab | B |
| G49852M | Benzoylecgonine (BZE) | B852M | Ab | B |
| Y01237B | Benzoylecgonine-BSA Conjugate | B | ||
| Y82115P | Benzoylecgonine Derivative (HRP) | B | ||
| G45020M | Benzoylecgonine/Cocaine | 3P1A6 | Ab | B |
| H01270M | Beta 2 Microglobulin | B625M | Ab | B |
| H42114M | Beta 2 Microglobulin | B1G6 | Ab | B |
| MCP17-301 | Beta 2 Microglobulin | 236-12301 | Ab | B |
| K31640S | Beta 2 Microglobulin (Affinity Purified) | Ab | B | |
| K62502G | Beta 2 Microglobulin (Purified) | Ab | B | |
| K90043C | Beta 2 Microglobulin (Purified) | Ab | B | |
| ILB1001 | Beta 2 Microglobulin, Human (Recombinant) | Protein | IR | |
| CB2-80A | Beta 2 Microglobulin (Affinity Purified), Host Chicken | Ab | I | |
| CB2-80A-Z | Beta 2 Microglobulin (Affinity Purified), Host Chicken | Ab | I | |
| E-80B2 | Beta 2 Microglobulin, Human | ELISA | I | |
| RB-9421 | Beta- actin | Ab | N | |
| RP-9884 | Beta-actin | Protein | N | |
| T01234R | Beta-actin, 43kDa (Affinity Purified), Host Rabbit | Ab | B | |
| K59041R | Beta Amylase (Sweet Potato) (Neat) | Ab | B | |
| K59147R | Beta Amylase (Sweet Potato) (Purified) | Ab | B | |
| Q2B910G | Beta Amyloid Cleaving Enzyme (BACE) Beta-Secretase C-terminal (Neat) | Ab | B | |
| A88420H | Beta Amyloid Cleaving Enzyme 2 (BACE 2) beta-Secretase N-term. (a.a. 44-59) | Protein | B | |
| MS-1329 | beta Galactosidase Ab-1 | BGAL01 | Ab | N |
| B59136R | Beta d Galactosidase (E. coli) (Purified) | Ab | B | |
| K03250K | Beta d Galactosidase (E. coli) (Affinity Purified) | Ab | B | |
| K03450R | Beta d Galactosidase (E. coli) (Affinity Purified) | Ab | B | |
| K45201M | Beta d Galactosidase (E. coli) | 2001 | Ab | B |
| K45220M | Beta d Galactosidase (E. coli) | 2002 | Ab | B |
| K86409M | Beta d Galactosidase (E. coli) | 2E9 | Ab | B |
| M2P46-236 | Beta Galactosidase (E. coli) | 236-16202 | Ab | B |
| CGAL-45A-Z | Beta Galactosidase (Affinity Purified), Host Chicken | Ab | I | |
| CGAL-45A | Beta Galactosidase (Affinity Purified), Host Chicken | Ab | I | |
| RGAL-45A-Z | Beta Galactosidase (Affinity Purified) | Ab | I | |
| RGAL-45A | Beta Galactosidase (Affinity Purified) | Ab | I | |
| A8A670H | Beta Galactosidase | Protein | B | |
| RABL-10A | Beta Lactoglobulin, Bovine (Affinity Purified) | Ab | I | |
| G55270M | Beta Lactamase | 8A5.A10 | Ab | B |
| H01261M | Beta-2 Glycoprotein I, Apolipoprotein H (Apo H) | B457M | Ab | B |
| A3C083H | Beta-2 Glycoprotein I, Apolipoprotein H (Apo H) | Protein | B | |
| IR100045 | Bilirubin, Conjugate Direct, Bovine | Protein | IR | |
| IR100056 | Bilirubin, Unconjugate (Indirect), Bovine | Protein | IR | |
| K99098M | Biotin | B098M | Ab | B |
| K11444M | Biotin | B169M | Ab | B |
| K59098F | Biotin (FITC) | Ab | B | |
| K59098G | Biotin (Affinity Purified) | Ab | B | |
| MS-1048 | Biotin Ab-2 | BTN.4 | Ab | N |
| GBIO-65A | Biotin (Affinity Purified) | Ab | I | |
| GBIO-65P | Biotin (HRP) | Ab | I | |
| J82100B | Blocking Buffer for ELISA | B | ||
| J82300B | Blocking Buffer for Lateral Flow Assays, PBS based | B | ||
| J82310B | Blocking Buffer for Lateral Flow Assays, Tris based | B | ||
| J82200B | Blocking Buffer for Western blot | B | ||
| N86583H | BNP and NT-proBNP Free Serum, Human | B | ||
| D87570R | Bone Morphogenetic Protein (BMP-1) C-terminal | Ab | B | |
| D87580R | Bone Morphogenetic Protein (BMP-1) CUB-2 Domain | Ab | B | |
| D87950R | Bone Morphogenetic Protein (BMP-1) N-terminal | Ab | B | |
| D24219R | Bone Sialoprotein (a.a. 108-122), Human | Ab | B | |
| D24223R | Bone Sialoprotein (a.a. 201-211), Human | Ab | B | |
| D24218R | Bone Sialoprotein (a.a. 262-279), Human | Ab | B | |
| D24224R | Bone Sialoprotein (a.a. 284-295), Human | Ab | B | |
| D24220R | Bone Sialoprotein (a.a. 39-47), Human | Ab | B | |
| D24422R | Bone Sialoprotein, Human | Ab | B | |
| H24232M | Bone Sialoprotein, Human | ID1.2 | Ab | B |
| C65500M | Bordetella pertussis (Purified) | BDI500 | Ab | B |
| B65302R | Borrelia burgdorferi (Lyme) (Purified) | Ab | B | |
| B65303F | Borrelia burgdorferi (Lyme) (FITC) | Ab | B | |
| B65304P | Borrelia burgdorferi (Lyme) (HRP) | Ab | B | |
| B65307B | Borrelia burgdorferi (Lyme) (Biotin) | Ab | B | |
| C65551M | Borrelia burgdorferi (Lyme) | 5016 | Ab | B |
| C65550M | Borrelia burgdorferi (Lyme) (OSP-A) | 5015 | Ab | B |
| C01481M | Borrelia burgdorferi (Lyme), flagellar antigen | B615M | Ab | B |
| C86420M | Borrelia burgdorferi (Lyme) garinii | Bg14 | Ab | B |
| C86520M | Borrelia burgdorferi (Lyme) sensu stricto | Bss42 | Ab | B |
| C86980M | Borrelia burgdorferi (Lyme) sensu stricto | Bss98 | Ab | B |
| R8A131 | Borrelia burgdorferi (Lyme) Osp-A 31kDa Recombinant | Protein | B | |
| R8A123 | Borrelia burgdorferi (Lyme) Osp-C Recombinant 23 kDa | Protein | B | |
| R70610 | Borrelia burgdorferi B31 (Lyme) | Protein | B | |
| R14210 | Borrelia burgdorferi (afzelii) (PKo) | Protein | B | |
| R29132 | Borrelia garinii | Protein | B | |
| IR57053 | Bovine Calf Thymus Extract | IR | ||
| IR-BV-GF | Bovine IgG | Protein | IR | |
| IBV-N | Bovine Plasma | IR | ||
| IBV-SER | Bovine Serum | IR | ||
| A64801B | Bovine Serum Albumin, Standard Powder | B | ||
| C5BP01-188 | Bovine Serum Albumin (BSA) | Ab | B | |
| A07100B | Bovine Spleen Extract | Protein | B | |
| A42452H | Brain Derived Neurotrophic Factor (BDNF) 28kDa, Recombinant | Protein | B | |
| H86507M | Brain Natriuretic Peptide (BNP) | 50B7 | Ab | B |
| H86051M | Brain Natriuretic Peptide (BNP) | 50E1 | Ab | B |
| H86245M | Brain Natriuretic Peptide (BNP) | 24C5 | Ab | B |
| H01255M | BNP and proBNP in immune complex with H86345M, Human | Ab-BNP2 | Ab | B |
| H01256M | BNP and proBNP in immune complex with H86345M, Human | Ab-BNP4 | Ab | B |
| H86262M | Brain Natriuretic Peptide (BNP) | 26E2 | Ab | B |
| H86290M | Brain Natriuretic Peptide (BNP) | 2G9 | Ab | B |
| H86573M | Brain Natriuretic Peptide (BNP) | 57H3 | Ab | B |
| K4A660R | Brain Natriuretic Peptide (BNP) (Neat) | Ab | B | |
| K4A670R | Brain Natriuretic Peptide (BNP) (Purified) | Ab | B | |
| K24410R | Brain Natriuretic Peptide (BNP) (a.a. 1-10) | Ab | B | |
| RBNP-80A | Brain Natriuretic Peptide (BNP) (Affinity Purified) | Ab | I | |
| RBNP-80A-Z | Brain Natriuretic Peptide (BNP) (Affinity Purified) | Ab | I | |
| IR100008 | Brain Natriuretic Peptide-32 | Protein | IR | |
| IR100009 | Brain Natriuretic Peptide-32, Pig | Protein | IR | |
| IR100055 | Brain Natriuretic Peptide-32, Rat | Protein | IR | |
| K55146R | BRCAA1 (a.a. 1046-1055) (Breast Cancer related gene) | Ab | B | |
| IBSCI-SER | Breast cancer serum - Stage I ductal carcinoma | IR | ||
| IPLA-0S-BSCI | Breast cancer plasma - Stage I ductal carcinoma | IR | ||
| IBSCII-SER | Breast cancer serum - Stage II ductal carcinoma | IR | ||
| IPLA-0S-BSCII | Breast cancer plasma - Stage II ductal carcinoma | IR | ||
| IBSCIII-SER | Breast cancer serum - Stage III ductal carcinoma | IR | ||
| IPLA-0S-BSCIII | Breast cancer plasma - Stage III ductal carcinoma | IR | ||
| IBSCIIL-SER | Breast cancer serum - Stage II lobular carcinoma | IR | ||
| IPLA-0S-BSCIIL | Breast cancer plasma - Stage II lobular carcinoma | IR | ||
| IR100042 | Breast Milk, Human | IR | ||
| MS-1058 | Bromodeoxyuridine Ab-3 | BRD.3 | Ab | N |
| MS-1848 | Bromodeoxyuridine (BrdU) Ab-4 | Bu20a | Ab | N |
| MBDU-65A | Bromodeoxyuridine (BrdU), Host Mouse | Ab | I | |
| MBDU-65A-Z | Bromodeoxyuridine (BrdU), Host Mouse | Ab | I | |
| CBDU-65A | Bromodeoxyuridine (BrdU), Host Chicken | Ab | I | |
| CBDU-65A-Z | Bromodeoxyuridine (BrdU), Host Chicken | Ab | I | |
| M20107S | Bromodeoxyuridine (BrdU) (Purified) | Ab | B | |
| M01269M | Bromodeoxyuridine (BrdU) (Purified), Host Rat | B684M | Ab | B |
| M01270F | Bromodeoxyuridine (BrdU) (FITC), Host Rat | B684M | Ab | B |
| M01271B | Bromodeoxyuridine (BrdU) (Biotin), Host Rat | B684M | Ab | B |
| M01272P | Bromodeoxyuridine (BrdU) (HRP), Host Rat | B684M | Ab | B |
| MAM22-871 | Bromodeoxyuridine (BrdU) | 131-14871 | Ab | B |
| C86118M | Brucella abortus BSCP31 | BrH1 | Ab | B |
| C86850M | Brucella abortus LPS | Bx85 | Ab | B |
| C86881M | Brucella abortus LPS | Bx88 | Ab | B |
| C86116M | Brucella abortus, intact cells | BrF11 | Ab | B |
| C86131M | Brucella abortus, intact cells | BrG11 | Ab | B |
| G01240M | Buprenorphine | B342M | Ab | B |
| Y01234B | Buprenorphine BTG | B | ||
| Y01235B | Buprenorphine BSA | B | ||
| IR7476414 | Busulfan | Ab | IR | |
|
A-Al AL-AZ B C-CD25 CD26-CD301 CDC-CY D E F G H I -IgG IgM-IT J K L M N O P-PL PM-PY Q R S T U V W X Y Z |